Exagen Inc. Common Stock
Symbol: XGN (NASDAQ)
11.74
▲ (0.13%) 0.015
Company Description:
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Key Stats
- Today's Open: $11.72
- Today's High: $11.858
- Today's Low: $11.645
- Today's Volume: 96.15K
- Yesterday Close: $11.72
- Yesterday High: $11.77
- Yesterday Low: $11.37
- Yesterday Volume: 200.31K
- Last Min Volume: 131
- Last Min High: $11.735
- Last Min Low: $11.735
- Last Min VWAP: $11.735
Company Profile
- Name: Exagen Inc. Common Stock
- Website: https://www.exagen.com
- Listed Date: 2019-09-19
- Location: VISTA, CA
- Market Status: Active
- CIK Number: 0001274737
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $257.88M
- Round Lot: 100
- Outstanding Shares: 22.00M
- Asset Type: CS
RECENT FILINGS FOR XGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-20 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-07-29 | 10-Q | View |
| 2025-07-29 | 8-K | View |
| 2025-07-17 | 8-K | View |
| 2025-07-02 | EFFECT | View |
| 2025-06-30 | CORRESP | View |
| 2025-06-30 | UPLOAD | View |
| 2025-06-20 | S-3 | View |
| 2025-06-12 | 4/A | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 8-K | View |
| 2025-05-20 | S-8 | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
Latest News on XGN